Fig. 3: SETD2 mutation and the efficacy of immunotherapy.
From: Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy
a The correlation between the frequencies of SETD2 mutation and objective response rates across multiple tumors. Red line, fitted curve; HNC, head and neck cancer. b Kaplan–Meier survival analysis stratified by SETD2 mutation status in 2734 cancer patients treated with immune checkpoint inhibitors. CI, confidence interval; HR, hazard ratio. c Multivariate analysis of the association between SETD2 mutation and overall survival.
